IrisMed
PrivateLast Round
Seed
Oct 24, 2024
Total Funding Raised
$370,000
Company Overview
IrisMed is a health-tech company that provides an AI-powered platform for optometry practices to automate insurance verification, optical quoting, billing, and patient recall.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, Vertical SaaS, Medical AI, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IrisMed Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
IrisMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 24, 2024 | ||||
| Accelerator | Mar 11, 2024 |
IrisMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Baker Bridge Capital | Seed |
| Techstars | Seed, Accelerator |
| Atlas SGR | Seed |
| Antler | Seed, Accelerator |
| Noemis Ventures | Seed, Accelerator |
| Banyan Ventures | Seed |
IrisMed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about IrisMed's valuation, stock price, and market status.